Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea
NCT01780207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2014-12-30
Summary
The purpose of this study in patients with obstructive sleep apnoea (OSA) and concomitant patent foramen ovale (PFO) is to assess the impact of percutaneous PFO closure on nocturnal hypoxemia and apnea/hypopnea, pulmonary and systemic artery pressure, endothelial function and arterial stiffness.
Conditions
Interventions
- DEVICE
-
PFO Closure
Sponsors & Collaborators
-
Insel Gruppe AG, University Hospital Bern
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2014-05-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) Obstructive Sleep Apnea Syndrome (OSAS)
NCT03640793 ·Status: COMPLETED ·Phase: NA
-
Recording of Multiple Nights Using a New Contactless Device (Sleepiz One Connect) in Obstructive Sleep Apnea
NCT05134402 ·Status: COMPLETED
-
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension
NCT01427192 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Suboptimal CPAP Therapy on Symptoms of Obstructive Sleep Apnoea
NCT02781740 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment
NCT01976052 ·Status: COMPLETED
-
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200 ·Status: RECRUITING
-
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010 ·Status: COMPLETED ·Phase: PHASE4
-
Minimally Invasive Detection of a Sleep Apnoea
NCT03760159 ·Status: TERMINATED
-
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
NCT01733784 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
NCT06283017 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea
NCT01475682 ·Status: UNKNOWN
-
Right Ventricular Function in Obstructive Sleep Apnea
NCT00640536 ·Status: COMPLETED
-
Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients
NCT02073305 ·Status: UNKNOWN
-
Virtual Surgery of the Upper Airways
NCT04829201 ·Status: RECRUITING
-
Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation
NCT02727192 ·Status: COMPLETED ·Phase: NA
-
Intraoral Appliance in the Treatment of Obstructive Sleep Apnea Syndrome in Obese
NCT03517150 ·Status: UNKNOWN ·Phase: NA
-
Breath Analysis in Obstructive Sleep Apnoea
NCT02050425 ·Status: COMPLETED ·Phase: NA
-
Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients
NCT07301021 ·Status: NOT_YET_RECRUITING
-
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
NCT00738179 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized-controlled Trial (RCT) on CPAP-withdrawal and Microvascular Function in OSA
NCT01797653 ·Status: COMPLETED ·Phase: NA
-
Italian PheNotypes Obstructive Sleep Apnea Study
NCT06872242 ·Status: RECRUITING
-
The Influence of MitraClip on Apnoea Asleep
NCT02615431 ·Status: UNKNOWN
-
Oxygen Saturation Patterns in Post-Op Patients at Risk for Obstructive Sleep Apnea
NCT01078207 ·Status: COMPLETED
-
Mechanisms for Atrial Fibrillation in Obstructive Sleep Apnea
NCT06465134 ·Status: RECRUITING
-
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
NCT03189173 ·Status: COMPLETED ·Phase: PHASE2